key: cord-0812720-6wiqws9f
authors: McCrossan, S.; Jivan, S.
title: Letter comments on: Cosmetic tourism during the COVID-19 pandemic: Dealing with the aftermath.
date: 2022-02-01
journal: J Plast Reconstr Aesthet Surg
DOI: 10.1016/j.bjps.2022.01.045
sha: 1e3a7a7513e3dc26c8301401a4fdb98d7dda6d0c
doc_id: 812720
cord_uid: 6wiqws9f

nan

A 25 year old female who had an augmentation-mastopexy and 11L abdominal liposuction in Turkey in July 2020, presented in August 2020 with mastopexy wound dehiscence and peri-implant infection. She had 48 hours intravenous antibiotics. She was reluctant to undergo explantation. She later re-presented in November 2020 with further peri-implant infection and again declined surgery. She therefore had a further 72 hours intravenous antibiotics followed by oral antibiotics. She has had regular dressing clinic and consultant follow up. At 9 months post operation, she is left with hypertrophic and hyperpigmented scars but retained implants. Case 2. A 47 year old male patient had an abdominoplasty in Pakistan in December 2020 during UK lockdown. He then presented to us in February 2021 with abdominal dehiscence and cellulitis requiring admission for intravenous antibiotics, surgical debridement and negative pressure wound therapy dressings. He had a total of 7 bed days in hospital. Frequent follow up shows the patient declined autologous skin grafts and resulted in prolonged dressing clinic follow up. He now has hyperpigmented and hypertrophic scarring of the lower abdominal wound. Examination showed she was pyrexial, had spanning yates drains in situ under an abdominal eschar. She was admitted for intravenous antibiotics, surgical debridement and negative pressure wound dressings, spending 4 days in hospital. After two negative wound swabs she then had delayed reconstruction with autologous skin grafts. See Figure 1 a and b.

Cosmetic tourism is increasingly popular often due to the cheaper options, shorter waiting lists and the associated holiday. 3 Our case series further highlights that patients are still keen to seek plastic surgery abroad despite lockdowns, restrictions on travel, fewer travel options and therefore increasing travel cost (self-isolation, PCR tests, increased airfare), and importantly the risk of catching and transmitting COVID-19. The pandemic also means that travelling back to the country where the surgery was performed to deal with a complication is very difficult and therefore these patients are treated locally, with costly theatre trips, bed days and prolonged dressing clinic visits. 4 With the NHS cancelling thousands of elective surgery including paediatric and cancer surgeries, it is hard to justify the NHS using valuable resources to treat complications of cosmetic tourism. Professional bodies for cosmetic surgery in each country must have more strict regulations for the risk and burden associated with cosmetic tourism especially during the pandemic. Particular attention also needs to be focused on travelling with open wounds and potential thromboembolic risks of travel after general anaesthetics and prolonged procedures.

Funding None

Not required

Cosmetic tourism during the COVID-19 pandemic: Dealing with the aftermath

Medical tourism in plastic surgery: ethical guidelines and practice standards for perioperative care

Medical Tourism in Aesthetic Breast Surgery: A Systematic Review

The complications of 'cosmetic tourism' -an avoidable burden on the NHS